Novartis's drug, Zarxio, contains the same active ingredient as Amgen's Neupogen, and once released would become the first biosimilar in the United States.
An internal Federal Trade Commission report recommended that the agency take action against Google for anticompetitive practices. The F.T.C. voted not to bring charges....